Dr. Gabayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8900 Wilshire Blvd
Beverly Hills, CA 90211Phone+1 310-432-8900Fax+1 310-432-8901- Is this information wrong?
Education & Training
Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1994 - 1997
Keck School of Medicine of the University of Southern CaliforniaClass of 1994
Certifications & Licensure
CA State Medical License 1996 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Start of enrollment: 2019 Sep 20
Publications & Presentations
PubMed
- 51 citationsElranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.Alexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, Nizar J Bahlis, H Miles Prince, Ruben Niesvizky, Paula Rodrίguez-Otero, Joaquin Martinez-Lopez, Guenther Koe...> ;Nature Medicine. 2023 Sep 1
- 32 citationsA Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid TumorsGregory L. Beatty, Safi Shahda, Thaddeus Beck, Nikhil Uppal, Steven J. Cohen, Ross C. Donehower, Afshin Eli Gabayan, Albert Assad, Julie Switzky, Hui-Ling Zhen, Daniel...> ;The Oncologist. 2019 Jan 1
- 35 citationsExtended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myelomaSundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber Camacho, David Irwin, Jose Lutzky, Marti McKinley, Phyllis Potts, Afshin Eli Gabayan, Amitabha Mazumder, Joh...> ;British Journal of Haematology. 2009 Sep 1
- Join now to see all
Press Mentions
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialMarch 20th, 2024- Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerJanuary 30th, 2024
- Kiromic BioPharma Partners with Beverly Hills Cancer Center for Groundbreaking Lung Cancer Study, USOctober 24th, 2023
- Join now to see all
Hospital Affiliations
Cedars-Sinai Medical CenterLos Angeles, California- Olympia Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
